Figure 5From: Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerIn vivo studies of DNL-Rap conjugates. (Rap)2-E1*-(Rap)2 was compared with (Rap)2-22*-(Rap)2 in a MDA-MB-468 xenograft model, showing tumor growth in individual mice in A, and survival curves in B; (Rap)2-22*-(Rap)2 was compared with (Rap)2-E1*-(Rap)2 in a disseminated Daudi model, showing survival curves in C.Back to article page